Can rare diseases be a viable option for the pharma industry?In this article, Christopher Ehinger questions whether rare diseases are a viable option for the pharma industry. He Share XCan rare diseases be a viable option for the pharma industry?https://pharmaphorum.com/views-and-analysis/can-rare-diseases-be-a-viable-option-for-the-pharma-industry/
Update on Attention Deficit Hyperactivity Disorder (ADHD) treatmentsIn our central nervous system disorders focus month, Suzanne McCarthy provides us with an update on the treatments Share XUpdate on Attention Deficit Hyperactivity Disorder (ADHD) treatmentshttps://pharmaphorum.com/views-and-analysis/update-on-attention-deficit-hyperactivity-disorder-adhd-treatments/
Success factors in value communication design – start with the key messageGijs Hubben presents part one of ‘Success factors in value communication design’, a set of articles that examines Share XSuccess factors in value communication design – start with the key messagehttps://pharmaphorum.com/views-and-analysis/success-factors-in-value-communication-design-start-with-the-key-message/
Increasing the value of new medicines: utilising the patients’ perspectiveDr Paul Stuart-Kregor of The MSI Consultancy discusses how to demonstrate real value of new medicinal products by Share XIncreasing the value of new medicines: utilising the patients’ perspectivehttps://pharmaphorum.com/views-and-analysis/increasing-the-value-of-new-medicines-utilising-the-patients-perspective/
Spotlight on… thyroid disease: hypothyroidismIn readiness for Thyroid Awareness Week (19th – 25th October), Lyn Mynott explains all about hypothyroidism including what Share XSpotlight on… thyroid disease: hypothyroidismhttps://pharmaphorum.com/views-and-analysis/spotlight-on-thyroid-disease-hypothyroidism/
Editor’s Voice: September – partnerships, pediatric care and our first round table debatepharmaphorum’s Hannah Blake provides an overview of the content published during the month of September on pediatric care Share XEditor’s Voice: September – partnerships, pediatric care and our first round table debatehttps://pharmaphorum.com/views-and-analysis/editor-s-voice-september-partnerships-pediatric-care-and-our-first-round-table-debate/
Pediatric pharmacology: interview with Dr Carlton LeeRebecca Aris interviews Dr Carlton Lee in pharmaphorum’s pediatric care themed month to hear his views on the Share XPediatric pharmacology: interview with Dr Carlton Leehttps://pharmaphorum.com/views-and-analysis/pediatric-pharmacology-interview-with-dr-carlton-lee/
Pitch perfect: 3 keys to successful BD communicationsAs our partnerships focus month draws to a close, Douglas MacDougall and Cory Tromblee discuss three key ways Share XPitch perfect: 3 keys to successful BD communicationshttps://pharmaphorum.com/views-and-analysis/macdougall-biomedical-communications/
Online adverse events: finding pharma’s needle in the electronic haystackIn the second part of this three article series exploring managing online adverse event tracking, Paul Tunnah continues Share XOnline adverse events: finding pharma’s needle in the electronic haystackhttps://pharmaphorum.com/views-and-analysis/online-adverse-events-finding-pharma-s-needle-in-the-electronic-haystack/
